Posted by Health Articles on February 2nd, 2011
Medication corporations make billions setting statin drugs to people with high cholesterol. Proof exists that statins lower cholesterol amounts. Now statins are branded as a drug that reduces the potential for heart attacks. However, a study of statin studies implies that drug corporations are fudging the information to support their marketing campaigns. It’s no surprise that corporations which take out installment loans to create merchandise skew their findings. Resource for this article – Review questions data supporting statins to prevent heart disease by MoneyBlogNewz.
Statin sales in billions for medication companies
There were $35 billion statin medication sales from medication corporations. This is what pharmaceutical consulting firm IMS explained. About $13.3 billion was sold last year of Lipitor which is a Pfizer statin drug. In fact, it was the number one selling medication within the world. In order to lower high cholesterol, several will take Lipitor. Millions will do this every year. AstraZeneca, in a race to catch up with Pfizer, has convinced the Food and Medication Administration to approve its statin Crestor as a drug for healthful individuals who want to prevent cardiovascular disease. You will find many people at a very low risk for heart disease though. These individuals don’t have several benefits which were discovered by a British research group who did a study on it.
Benefit of drug corporations happens with skewed statin drug studies
The Cochrane Database of Systematic Reviews did a study of 14 different statin drugs. There isn’t any evidence that claims statins needs to be taken by individuals with low risk of heart disease. There isn’t any evidence at all that it helps. There isn’t any evidence to show that a person unlikely to get a heart attack advantages from taking statins. There is evidence that it helps those who have already had a heart attack prevent it from occurring again though. There were relationships between medication companies and scientists employed too, according to Cochrane scientists. The outcomes were chosen by the scientists due to the data chosen to be used. Pharmaceutical companies argue that it is all in how “low risk” is defined and that statin drugs save money in the health care system because they’re cheaper than surgery and other forms of treatment.
Advantages aren’t enough to over-shadow statin unwanted effects
Statin drugs help people genetically predisposed to high cholesterol protect their health. However, statin advantages come with unwanted effects such as memory loss and degeneration of muscle tissue, as well as liver and kidney problems. Statin drugs are accessible by prescription and sold over the counter. Physicians commenting on the Cochrane statin review suggested that people see their doctor to determine their risk level for heart disease before taking statins. It is bad to take it if there is a very low risk level. This means you will experience negative effects without a benefit.